Anne Robinson

Royal Alexandra Children's Hospital — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index5.5kcitations210works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(152), Microscopic Colitis(126), Eosinophilic Esophagitis(24), Immunodeficiency and Autoimmune Disorders(18), Autoimmune and Inflammatory Disorders(18)

Publications210 total

OC100 Multiple micronutrient and trace element deficiencies (including scurvy) presenting in a child with kwashiorkor from a significantly restricted oral diet
2025
An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-112 in human leukocyte antigen-C*08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation.
Journal of Clinical Oncology·2024· 3 cited
AB-101, an allogeneic, non–genetically modified, natural killer (NK) cell therapy, evaluated as monotherapy or in combination with rituximab in R/R non-Hodgkin lymphoma.
Journal of Clinical Oncology·2023· 3 cited
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial
The Lancet·2022· 296 cited
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
The Lancet·2022· 365 cited
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results
Gastroenterology·2022· 71 citedOpen Access
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results
Gastroenterology·2022· 79 citedOpen Access
Trends in antimicrobial susceptibility patterns in N. gonorrhoea in Australia: Systematic review and meta-regression analysis
International Journal of Infectious Diseases·2020Open Access
S0881 Therapeutic Drug Monitoring Dosing Regimen With Adalimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the SERENE-UC Maintenance Study
The American Journal of Gastroenterology·2020· 3 cited
S0648 Clinically Adjusted vs Therapeutic Drug Monitoring Dosing Regimens With Adalimumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the SERENE-CD Maintenance Study
The American Journal of Gastroenterology·2020· 6 cited
945 HIGHER VERSUS STANDARD ADALIMUMAB MAINTENANCE REGIMENS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE SERENE-UC MAINTENANCE STUDY
Gastroenterology·2020· 2 cited
Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn’s disease: results from a randomized trial
Therapeutic Advances in Gastroenterology·2020· 49 citedOpen Access
OP01 Higher vs. standard adalimumab maintenance regimens in patients with moderately to severely active ulcerative colitis: Results from the SERENE-UC maintenance study
Journal of Crohn s and Colitis·2020· 20 cited
Anne Robinson
Authors group·2019
Challenges in IBD Research: Pragmatic Clinical Research
Inflammatory Bowel Diseases·2019· 27 citedOpen Access
A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN’S DISEASE WITH ADALIMUMAB-BASED TREATMENT: ECONOMIC EVALUATION OF CALM TRIAL FROM CANADIAN PERSPECTIVE
Journal of the Canadian Association of Gastroenterology·2019Open Access
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry
Inflammatory Bowel Diseases·2019· 22 citedOpen Access
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn’s Disease Studies
Journal of Crohn s and Colitis·2019· 45 citedOpen Access
The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn’s disease: a post hoc analysis
Alimentary Pharmacology & Therapeutics·2018· 25 cited
Anorectal Abscess and Fistula-in-Ano
2018· 24 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

William J. Sandborn(27), Roopal Thakkar(19), Remo Panaccione(17), Geert D’Haens(15), Bidan Huang(11), Qian Zhou(11), Joel Petersson(9), Jean‐Frédéric Colombel(8), Brian G. Feagan(8), Laurent Peyrin‐Biroulet(8), Walter Reinisch(8), Stefan Schreiber(7), Jean–Frédéric Colombel(7), Silvio Danese(6), Edward V. Loftus(6), Julián Panés(6), Sofie Berg(6), Jasmina Kalabic(6), Jen‐Fue Maa(6), Kori Wallace(5)